Robert A. Kyle
Impact in
- Hematology top 0.01%
- Multiple Myeloma Research and Treatments
- Genetics top 0.1%
- Chronic Lymphocytic Leukemia Research
Papers in
- Hematology 719
- Multiple Myeloma Research and Treatments 703
-
- History of Science and Medicine 173
- Co-authors
- S. Vincent Rajkumar (251 shared papers)Morie Abraham Gertz (251 shared papers)Angela A. Dispenzieri (251 shared papers)Philip R. Greipp (154 shared papers)Martha Q. Lacy (224 shared papers)John Anthony Lust (145 shared papers)Shaji Kunnathu Kumar (235 shared papers)Terry M. Therneau (63 shared papers)
- Journals
- Mayo Clinic Proceedings (266 papers)Blood (215 papers)Leukemia (83 papers)American Journal of Hematology (80 papers)JAMA (54 papers)
- Partner nations
- United StatesUnited KingdomItaly
In The Last Decade
Robert A. Kyle
1.3k papers receiving 97.6k citations
Robert A. Kyle's Hit Papers
Peers
Comparison fields: 5 of 190
- Hematology 62.3k
- Genetics 4.8k
- Molecular Biology 20.3k
- Nephrology 1.8k
- Oncology 4.1k
Countries citing papers authored by Robert A. Kyle
This map shows the geographic impact of Robert A. Kyle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert A. Kyle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert A. Kyle more than expected).
Fields of papers citing papers by Robert A. Kyle
This network shows the impact of papers produced by Robert A. Kyle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert A. Kyle. The network helps show where Robert A. Kyle may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert A. Kyle, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 1.4k papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma Hit paper breakdown → | 2014 | 3623 |
| 2 | International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma Hit paper breakdown → | 2016 | 2403 |
| 3 | International Staging System for Multiple Myeloma Hit paper breakdown → | 2005 | 2318 |
| 4 | International uniform response criteria for multiple myeloma Hit paper breakdown → | 2006 | 2290 |
| 5 | Improved survival in multiple myeloma and the impact of novel therapies Hit paper breakdown → | 2007 | 1921 |
| 6 | Review of 1027 Patients With Newly Diagnosed Multiple Myeloma Hit paper breakdown → | 2003 | 1846 |
| 7 | A Long-Term Study of Prognosis in Monoclonal Gammopathy of Undetermined Significance Hit paper breakdown → | 2002 | 1159 |
| 8 | Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients Hit paper breakdown → | 2013 | 1150 |
| 9 | Multiple Myeloma Hit paper breakdown → | 2004 | 1116 |
| 10 | Prevalence of Monoclonal Gammopathy of Undetermined Significance Hit paper breakdown → | 2006 | 1099 |
| 11 | Primary systemic amyloidosis: clinical and laboratory features in 474 cases. Hit paper breakdown → | 1995 | 999 |
| 12 | Criteria for diagnosis, staging, risk stratification and response assessment of multiple myeloma Hit paper breakdown → | 2008 | 920 |
| 13 | Consensus recommendations for the uniform reporting of clinical trials: report of the International Myeloma Workshop Consensus Panel 1 Hit paper breakdown → | 2011 | 919 |
| 14 | Multiple myeloma Hit paper breakdown → | 2017 | 911 |
| 15 | Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study Hit paper breakdown → | 2009 | 884 |
| 16 | Revised Prognostic Staging System for Light Chain Amyloidosis Incorporating Cardiac Biomarkers and Serum Free Light Chain Measurements Hit paper breakdown → | 2012 | 872 |
| 17 | Serum Cardiac Troponins and N-Terminal Pro-Brain Natriuretic Peptide: A Staging System for Primary Systemic Amyloidosis Hit paper breakdown → | 2004 | 778 |
| 18 | Treatment of multiple myeloma with high-risk cytogenetics: a consensus of the International Myeloma Working Group Hit paper breakdown → | 2016 | 747 |
| 19 | Multiple myeloma Hit paper breakdown → | 2008 | 723 |
| 20 | Clinical Course and Prognosis of Smoldering (Asymptomatic) Multiple Myeloma Hit paper breakdown → | 2007 | 704 |
About Robert A. Kyle
Robert A. Kyle is a scholar working on Hematology, History and Philosophy of Science, History, Genetics and Molecular Biology, having authored 1.4k papers that have together received 103.2k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (703 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (286 papers), History of Science and Medicine (173 papers), Medical History and Innovations (103 papers), Chronic Lymphocytic Leukemia Research (81 papers), Biographical and Historical Analysis (44 papers), Historical Medical Research and Treatments (27 papers) and History of Medical Practice (21 papers). The work is most often cited by research in Hematology (62.3k citations), Genetics (4.8k citations), Molecular Biology (20.3k citations), Nephrology (1.8k citations) and Oncology (4.1k citations). Robert A. Kyle has collaborated with scholars based in United States, United Kingdom and Italy. Frequent co-authors include S. Vincent Rajkumar, Morie Abraham Gertz, Angela A. Dispenzieri, Philip R. Greipp, Martha Q. Lacy, John Anthony Lust, Shaji Kunnathu Kumar, Terry M. Therneau, Dirk R. Larson and Rafaël Fonseca. Their work appears in journals such as Mayo Clinic Proceedings, Blood, Leukemia, American Journal of Hematology and JAMA.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.